TrialReader


Animal and Plant Proteins and Glucose Metabolism

NCT03994367 — Not applicable, Recruiting, 100 participants, University of Missouri-Columbia

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT03994367, acronym HP
StatusRecruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, prevention
Enrollment100 (Estimated)
SponsorUniversity of Missouri-Columbia (Other)
ConditionsMetabolic Syndrome, Metabolic Syndrome, Protection Against, Glucose Metabolism Disorders
InterventionsHigh animal protein isolate, High animal protein whole food, High plant protein isolate, High plant protein whole food (Other)
Datesstart 2019-07-12, primary completion 2028-02-25 (estimated), completion 2028-04-25 (estimated), first posted 2019-06-21, last updated 2026-05-08
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Metabolic Syndrome All trials for Metabolic Syndrome, Protection Against All trials of High animal protein isolate All trials of High animal protein whole food

-Summary

The goal of this proposal is to determine the effect of a high protein diet in which the increase in protein intake is derived from different sources (animal vs plant and protein-rich whole foods vs protein isolates) on: i) liver and muscle insulin sensitivity; ii) the metabolic response to a meal, and iii) 24-h plasma concentration profiles of glucose, glucoregulatory hormones, and protein-derived metabolites purported to cause metabolic dysfunction.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Standard protein (control)No intervention
High animal protein isolateExperimentalOther: High animal protein isolate
High animal protein whole foodExperimentalOther: High animal protein whole food
High plant protein isolateExperimentalOther: High plant protein isolate
High plant protein whole foodExperimentalOther: High plant protein whole food
  • High animal protein isolate (Other): Increased dietary protein content from animal protein isolates
  • High animal protein whole food (Other): Increased dietary protein content from animal protein whole food
  • High plant protein isolate (Other): Increased dietary protein content from plant protein isolates
  • High plant protein whole food (Other): Increased dietary protein content from animal protein whole food

+Outcome measures

Primary outcomes

  • 24-hour plasma glucose concentration [up to 12 weeks after the intervention]
  • Insulin sensitivity assessed as insulin-mediated glucose disposal during a hyperinsulinemic-euglycemic clamp procedure [up to 12 weeks after the intervention]

Secondary outcomes

  • Postprandial plasma glucose concentration [up to 12 weeks after the intervention]
  • mTOR signaling (phospho-S6 content) in circulating monocytes [up to 12 weeks after the intervention]
  • Endothelial function, assessed as reactive hyperemia index [up to 12 weeks after the intervention]
  • Postprandial plasma insulin concentration [up to 12 weeks after the intervention]
  • Postprandial plasma amino acid concentration [up to 12 weeks after the intervention]

+Eligibility

Sex: All, ages: 21 Years to 70 Years, accepts healthy volunteers

Inclusion Criteria:

* age: ≥21 and ≤70 years;
* BMI: >24.5 and <32.5 kg/m2;
* habitual protein intake <0.9 g/kg/day (assessed on 2 weekdays and 2 weekend days by using the HealthWatch 360 app); and
* weight stable (i.e., ≤3% change) and untrained (≤150 min of structured exercise/week) for at least 2 months before entering the study.

Exclusion Criteria:

* prediabetes or type 2 diabetes;
* evidence of chronic kidney disease by medical history or laboratory tests (glomerular filtration rate <60 ml/min/1.73 m2 or an albumin to creatinine ratio in urine ≥30 mg/g);
* vegetarians or vegans;
* intolerance or allergies to ingredients in the metabolic meal or intervention diet;
* take dietary supplements (e.g., pre- and probiotics, fiber, fish oil) or medications known to affect our study outcomes;
* received antibiotic or antifungal treatment (which affect the microbiome and therefore microbial metabolite production) 2 months before entering the study;
* consume tobacco products or excessive alcohol (women: >14 drinks/week; men: >21 drinks/week);
* evidence of significant organ system dysfunction or diseases (e.g., cirrhosis), and
* unwilling or unable to provide informed consent.

+Locations (1)

FacilityCityCountryStatus
University of Missouri School of MedicineColumbia, MissouriUnited StatesRecruiting

+Publications

  • Results publication: Fappi A, Shabrish V, Hollomon H, Islam T, Zhang X, Razani B, Klein S, Mittendorfer B. High animal protein and high plant protein meals differentially alter postprandial plasma amino acid concentrations but not glucose homeostasis in people with overweight/obesity in a randomized, cross-over, single-meal study. Am J Clin Nutr. 2026 Aug 10:101468. doi: 10.1016/j.ajcnut.2026.101468. Online ahead of print. PMID 42575285

+Investigators

My Notes